News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
499,113 Results
Type
Article (10213)
Company Profile (154)
Press Release (488840)
Multimedia
Podcasts (18)
Webinars (6)
Section
Business (171092)
Career Advice (345)
Deals (26333)
Drug Delivery (12)
Drug Development (55728)
Employer Resources (18)
FDA (10112)
Job Trends (9078)
News (245536)
Policy (18432)
Tag
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Genetown Standard (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (3)
Academia (683)
Academic (1)
Accelerated approval (23)
ADA (20)
Adcomms (1)
Allergies (162)
Alliances (34315)
ALS (106)
Alzheimer's disease (1014)
Antibody-drug conjugate (ADC) (294)
Approvals (10775)
Artificial intelligence (383)
ASCO (178)
Autoimmune disease (274)
Automation (29)
Bankruptcy (264)
Best Places to Work (7449)
BIO (40)
BIOSECURE Act (2)
Biosimilars (162)
BioSpace Insights (31)
Biotechnology (100)
Bladder cancer (140)
Brain cancer (35)
Breast cancer (515)
Cancer (3949)
Cardiovascular disease (230)
Career advice (286)
Career pathing (3)
CAR-T (196)
CDC (7)
Celiac Disease (2)
Cell therapy (529)
Cervical cancer (35)
Clinical research (50251)
Collaboration (1417)
Commercialization (3)
Compensation (1408)
Complete response letters (35)
COVID-19 (946)
CRISPR (66)
C-suite (829)
Cystic fibrosis (89)
Data (6046)
Denatured (11)
Depression (104)
Dermatology (76)
Diabetes (351)
Diagnostics (4299)
Digital health (40)
Diversity (1)
Diversity, equity & inclusion (6)
Drug discovery (195)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (168)
Earnings (74124)
Editorial (2)
Employer branding (2)
Employer resources (18)
Events (89859)
Executive appointments (766)
FDA (12883)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (18)
Frontotemporal dementia (23)
Funding (1011)
Gene editing (136)
Generative AI (17)
Gene therapy (334)
GLP-1 (329)
Government (1073)
Grass and pollen (6)
Guidances (298)
Healthcare (9865)
Hematology (112)
HIV (58)
Huntington's disease (23)
IgA nephropathy (69)
Immunology and inflammation (280)
Immuno-oncology (69)
Indications (166)
Infectious disease (1161)
Inflammatory bowel disease (169)
Inflation Reduction Act (8)
Influenza (89)
Intellectual property (253)
Interviews (48)
IPO (12631)
IRA (6)
Job creations (2032)
Job search strategy (271)
JPM (15)
Kidney cancer (16)
Labor market (2)
Layoffs (95)
Leadership (2)
Legal (5227)
Licensing (2)
Liver cancer (49)
Longevity (17)
Lung cancer (565)
Lymphoma (270)
Machine learning (32)
Management (3)
Manufacturing (577)
Marketing (8)
MASH (118)
Medical affairs (1)
Medical device (8692)
Medtech (8826)
Mergers & acquisitions (14736)
Metabolic disorders (740)
mRNA (74)
Multiple sclerosis (117)
NASH (4)
Neurodegenerative disease (235)
Neuropsychiatric disorders (43)
Neuroscience (1919)
NextGen: Class of 2026 (3263)
Non-profit (1001)
Now hiring (9)
Obesity (249)
Opinion (18)
Ovarian cancer (172)
Pain (175)
Pancreatic cancer (201)
Parkinson's disease (214)
Partnered (13)
Patents (476)
Patient recruitment (534)
Peanut (59)
People (43002)
Pharmaceutical (32)
Pharmacy benefit managers (8)
Phase 1 (16235)
Phase 2 (22364)
Phase 3 (15261)
Pipeline (7321)
Policy (36)
Postmarket research (1648)
Preclinical (6941)
Press Release (38)
Prostate cancer (197)
Psychedelics (8)
Radiopharmaceuticals (194)
Rare diseases (605)
Real estate (3137)
Recruiting (8)
Regulatory (15388)
Reports (17)
Research institute (806)
Resumes & cover letters (46)
Rett syndrome (40)
RNA editing (7)
RSV (49)
Schizophrenia (113)
Series A (189)
Series B (129)
Service/supplier (4)
Sickle cell disease (67)
Special edition (1)
Spinal muscular atrophy (90)
Sponsored (8)
Startups (2192)
Stomach cancer (3)
Supply chain (52)
Tariffs (7)
The Weekly (7)
Vaccines (446)
Venture capital (34)
Weight loss (84)
Women's health (77)
Date
Today (75)
Last 7 days (406)
Last 30 days (1302)
Last 365 days (20574)
2026 (12122)
2025 (20486)
2024 (24228)
2023 (27799)
2022 (36009)
2021 (38749)
2020 (34820)
2019 (24293)
2018 (18263)
2017 (19553)
2016 (18602)
2015 (24880)
2014 (22098)
2013 (18465)
2012 (20512)
2011 (20741)
2010 (20591)
Location
Africa (247)
Alabama (85)
Alaska (2)
Arizona (312)
Arkansas (11)
Asia (19762)
Australia (2352)
California (11905)
Canada (3183)
China (778)
Colorado (471)
Connecticut (405)
Delaware (276)
Europe (29156)
Florida (1752)
Georgia (370)
Hawaii (3)
Idaho (46)
Illinois (783)
India (57)
Indiana (353)
Iowa (13)
Japan (461)
Kansas (104)
Kentucky (30)
Louisiana (25)
Maine (25)
Maryland (1197)
Massachusetts (8040)
Michigan (301)
Minnesota (554)
Mississippi (4)
Missouri (80)
Montana (24)
Nebraska (12)
Nevada (139)
New Hampshire (63)
New Jersey (2809)
New Mexico (15)
New York (2820)
North Carolina (1273)
North Dakota (4)
Northern California (5976)
Ohio (276)
Oklahoma (14)
Oregon (18)
Pennsylvania (2246)
Puerto Rico (24)
Rhode Island (31)
South America (420)
South Carolina (75)
South Dakota (1)
Southern California (4902)
Tennessee (118)
Texas (1933)
United States (39274)
Utah (356)
Vermont (1)
Virginia (168)
Washington D.C. (42)
Washington State (924)
West Virginia (1)
Wisconsin (76)
499,113 Results for "triumvira immunologics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
June 18, 2026
·
8 min read
Funding
Degron adds $40M to series A, supporting immunology plans for molecular glue platform
Degron Therapeutics will have stiff competition in immunology, as Novartis inked a $5.7 billion agreement with Monte Rosa Therapeutics last year to develop molecular glues for undisclosed immune-mediated conditions.
May 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class anti-CD122 Antibody, FB102, to its Immunology Pipeline
July 27, 2026
·
12 min read
Press Releases
AbbVie to Acquire Apogee Therapeutics, Deepening Immunology Portfolio
June 22, 2026
·
17 min read
Press Releases
Harbour BioMed Appoints Dr. Lloyd Klickstein as Scientific Advisor for Immunology
June 29, 2026
·
3 min read
Press Releases
Triumvira Immunologics Presents Updated Clinical Data at the 2025 ASCO Gastrointestinal Cancers Symposium
January 27, 2025
·
2 min read
Press Releases
Equillium Announces Poster Presentations at IMMUNOLOGY2026™, the Annual Meeting of the American Association of Immunologists
April 8, 2026
·
2 min read
Deals
Alternative funding strategies to discuss at JPM with Halia Therapeutics, the ADDF and Triumvira Immunologics
BioSpace and guests from Halia Therapeutics, Triumvira Immunologics and the Alzheimer’s Drug Discovery Foundation discuss alternative financing strategies to consider for 2024. Listen now.
January 4, 2024
·
1 min read
·
BioSpace Insights
Triumvira Immunologics to Present Clinical Data at the 2024 ASCO Gastrointestinal Cancers Symposium
Triumvira Immunologics today announced that it will present two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium in San Francisco, California, from January 18-20, 2024.
December 19, 2023
·
3 min read
Press Releases
Chai Discovery Enters Into Collaboration Agreement With argenx to Advance AI-Driven Immunology Breakthroughs
July 16, 2026
·
2 min read
1 of 49,912
Next
